Table 3.
Ventral Striatal BPND by Group, Drink Order, and Beverage Day
| Group | ||||||
|---|---|---|---|---|---|---|
| FHP | FHN | AUD | ||||
| Drink Order | ||||||
| AP (n = 8) | PA (n = 8) | AP (n = 15) | PA (n = 17) | AP (n = 8) | PA (n = 7) | |
| VST BPND Placebo Day | 2.42 ± 0.16 | 2.18 ± 0.27 | 2.44 ± 0.28 | 2.39 ± 0.28 | 2.26 ± 0.24 | 2.49 ± 0.26 |
| VST BPND Alcohol Day | 2.14 ± 0.21 | 2.12 ± 0.28 | 2.31 ± 0.30 | 2.20 ± 0.23 | 2.17 ± 0.23 | 2.30 ± 0.17 |
Values represent mean ± SD.
AP, alcohol beverage at first positron emission tomography scan; AUD, alcohol use disorder; BPND, binding potential; FHN, family history–negative; FHP, family history–positive; PA, alcohol beverage at second positron emission tomography scan; VST, ventral striatum.